FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLD - Martina Colognesi; Daniela Gabbia; Anna Signor; Stefano Comai; Andrea Mattarei; Gianfranco Pasut; Lucia Centofanti; Stefano La Rosa; Giovanna Finzi; Franco Folli; M. Pappagallo; Paolo L. Manfredi; et al. (Journal of Hepatology, 2025)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com